Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03541525 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT03541525 · ClinicalTrials.gov record · last posted 2025-04-30

Pathophysiological Explorations of Red Blood Cells

Study acronym: GR-Ex
StatusRecruiting
PhaseNot specified
Started2017-10-16
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
GR-Ex is a program labelled by Labex (Laboratory of Excellence) by the French Ministry of Higher Education and Research. This program aims to develop the means to improve knowledge in the physiology and pathologies of erythropoiesis, red blood cells and iron metabolism, and to develop new therapeutic protocols capable of providing added value in terms of innovation.

Amendment record 4 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 4 times since 2018-05-17; most recent amendment 2025-04-29. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT03541525
Lead Sponsor Imagine Institute
Conditions Red Blood Cell Disorder
Enrollment 3,750 participants
Start Date 2017-10-16
Primary Completion 2037-10-15 (estimated)
Study Completion 2037-10-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-30